Search - tctmd.com

Displaying 121 - 140 of 162

Sort: Relevancy | Date

News Daily News

Low Incidence of A-fib Seen in Elite Athletes, Including Runners and Triathletes

Michael O'Riordan

November 02, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Daily News

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Michael O'Riordan

October 15, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Daily News

Global Burden of HIV-Related CVD Has Tripled Over Two Decades

Lucy Hicks

July 13, 2018

News Daily News

It Takes a Village: Diverse Gut Microbes Linked to Arterial Health in Women

Caitlin E. Cox

May 15, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Inflammatory Bowel Disease May Up the Risk of MI, Especially in Young People

L.A. McKeown

March 09, 2018

News Daily News

Varicose Veins Linked to Increased Risk of DVT

L.A. McKeown

February 28, 2018

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

News Conference News AHA 2017

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Michael O'Riordan

November 16, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Another Study Challenges Notion of ‘Healthy Obese’

L.A. McKeown

September 11, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Advertisement

Low Incidence of A-fib Seen in Elite Athletes, Including Runners and Triathletes

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Global Burden of HIV-Related CVD Has Tripled Over Two Decades

It Takes a Village: Diverse Gut Microbes Linked to Arterial Health in Women

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Inflammatory Bowel Disease May Up the Risk of MI, Especially in Young People

Varicose Veins Linked to Increased Risk of DVT

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Another Study Challenges Notion of ‘Healthy Obese’

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content